| Autor: |
Patrick Vanderheyden, Kalyan Tirupula, Walter G. Thomas, Laura Storjohann, Leigh Stoddart, Eliot Spindel, Michael Spedding, Joanna L. Sharman, Jean-Philippe Pin, Adam J Pawson, Richard Neubig, Chido Mpamhanga, Amy E. Monaghan, Wen Chiy Liew, Evi Kostenis, Sadashiva Karnik, Robert T. Jensen, Nick Holliday, Anthony Harmar, Satoru Eguchi, Khuraijam Dhanachandra Singh, Anthony P. Davenport, Tom I. Bonner, Richard V. Benya, Helen E. Benson, Jim Battey, Stephen P.H. Alexander |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
IUPHAR/BPS Guide to Pharmacology CITE. 2022 |
| ISSN: |
2633-1020 |
| DOI: |
10.2218/gtopdb/f16/2022.3 |
| Popis: |
Table 1 lists a number of putative GPCRs identified by NC-IUPHAR [161], for which preliminary evidence for an endogenous ligand has been published, or for which there exists a potential link to a disease, or disorder. These GPCRs have recently been reviewed in detail [121]. The GPCRs in Table 1 are all Class A, rhodopsin-like GPCRs. Class A orphan GPCRs not listed in Table 1 are putative GPCRs with as-yet unidentified endogenous ligands.Table 1: Class A orphan GPCRs with putative endogenous ligands GPR3GPR4GPR6GPR12GPR15GPR17GPR20 GPR22GPR26GPR31GPR34GPR35GPR37GPR39 GPR50GPR63GPR65GPR68GPR75GPR84GPR87 GPR88GPR132GPR149GPR161GPR183LGR4LGR5 LGR6MAS1MRGPRDMRGPRX1MRGPRX2P2RY10TAAR2 In addition the orphan receptors GPR18, GPR55 and GPR119 which are reported to respond to endogenous agents analogous to the endogenous cannabinoid ligands have been grouped together (GPR18, GPR55 and GPR119). |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
